These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antagonism of vasopressin-induced coronary artery constriction by the vasopressin antagonist d(CH2)5Tyr(Me)-AVP. Kopia GA; Valocik RE J Cardiovasc Pharmacol; 1985; 7(5):958-63. PubMed ID: 2413308 [TBL] [Abstract][Full Text] [Related]
7. Skin blood flow and cigarette smoking: the role of vasopressin. Waeber B; Schaller MD; Nussberger J; Bussien JP; Hofbauer KG; Brunner HR Clin Exp Hypertens A; 1984; 6(10-11):2003-6. PubMed ID: 6532586 [TBL] [Abstract][Full Text] [Related]
8. Blood pressure and heart rate effect of a vasopressin antagonist in conscious normotensive rats pretreated with exogenous vasopressin. Waeber B; Nussberger J; Brunner HR Eur J Pharmacol; 1983 Jul; 91(1):135-7. PubMed ID: 6688586 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic role of vasopressin released during Finnish sauna. Bussien JP; Gaillard RC; Nussberger J; Waeber B; Hofbauer KG; Turnill D; Brögger R; Brunner HR Acta Endocrinol (Copenh); 1986 Jun; 112(2):166-71. PubMed ID: 3755560 [TBL] [Abstract][Full Text] [Related]
10. The differential effect of arginine vasopressin on skin blood flow in man. Wiles PG; Grant PJ; Davies JA Clin Sci (Lond); 1986 Dec; 71(6):633-8. PubMed ID: 3791864 [TBL] [Abstract][Full Text] [Related]
11. The role of vasopressin in the regional vascular responses evoked in the spontaneously breathing rat by systemic hypoxia. Louwerse AM; Marshall JM J Physiol; 1993 Oct; 470():463-72. PubMed ID: 8308738 [TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure]. Nicod P; Goy J; Waeber B; Bussien JP; Turini GA; Nussberger J; Hofbauer KG; Brunner HR Schweiz Med Wochenschr; 1985 Dec; 115(50):1823-5. PubMed ID: 3841412 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Schaller MD; Waeber B; Nussberger J; Brunner HR Am J Physiol; 1985 Dec; 249(6 Pt 2):H1086-92. PubMed ID: 3907375 [TBL] [Abstract][Full Text] [Related]
14. Development of high sodium renal hypertension during chronic blockade of the vascular effects of vasopressin. Hinojosa C; Haywood JR J Pharmacol Exp Ther; 1986 Aug; 238(2):492-6. PubMed ID: 2874211 [TBL] [Abstract][Full Text] [Related]
15. Effect of vasopressin on production of cerebrospinal fluid: possible role of vasopressin (V1)-receptors. Faraci FM; Mayhan WG; Heistad DD Am J Physiol; 1990 Jan; 258(1 Pt 2):R94-8. PubMed ID: 2137302 [TBL] [Abstract][Full Text] [Related]
16. Role of vasopressin in renal vascular changes with hypoxemia and hypercapnic acidosis in conscious dogs. Rose CE; Ragsdale NV; Carey RM Am J Physiol; 1990 Oct; 259(4 Pt 2):R690-702. PubMed ID: 2145777 [TBL] [Abstract][Full Text] [Related]
17. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin? Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119 [TBL] [Abstract][Full Text] [Related]
18. Vasopressin and angiotensin in the control of arterial pressure and regional blood flow in anaesthetized, surgically stressed rats. Pang CC Can J Physiol Pharmacol; 1983 Dec; 61(12):1494-500. PubMed ID: 6689477 [TBL] [Abstract][Full Text] [Related]
19. Vasoconstrictor role for vasopressin in conscious, sodium-depleted rats. Jover B; Dupont M; Mimran A; Woods R; McGrath B Am J Physiol; 1987 Oct; 253(4 Pt 2):H763-9. PubMed ID: 2889370 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological evaluation of d(CH2)5Tyr(Me)AVP as an antagonist of vasopressin-induced contraction of the isolated rat caudal artery. Clineschmidt BV; Lis EV Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):72-84. PubMed ID: 2950833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]